ARKGvsPTHETF Comparison
VS
ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. ARKG's top 1 sector exposures are Healthcare. In contrast, PTH's top sector exposures are Healthcare and Consumer Non-Cyclicals. ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.72% for PTH. ARKG is up 55.33% year-to-date (YTD) with +$52M in YTD flows. PTH performs worse with 21.86% YTD performance, and +$131M in YTD flows. Run a side-by-side ETF comparison of ARKG and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG vs PTH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG PTH | +2.26%-0.65% | +38.05%+23.89% | +55.33%+21.86% | +83.03%+55.10% | +43.84%+69.72% | -45.48%+8.42% |
| Flows | ARKG PTH | +$26M+$26M | +$132M+$142M | +$52M+$131M | +$69M+$138M | -$505M+$78M | -$2.24B-$151M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG PTH | +43.14%+28.61% | +44.21%+26.06% | +43.94%+26.01% | +46.36%+25.76% |
| Max drawdown | ARKG PTH | -13.89%-7.42% | -27.52%-11.91% | -46.41%-27.71% | -78.04%-49.87% |
| Max drawdown duration | ARKG PTH | 32d40d | 126d140d | 882d353d | 1817d1735d |
Trading data
ARKG | PTH | |
Last sale 9/11/2026 at 6:40 PM | $45.75 | $61.84 |
| Previous close 09/10/2026 | $45.38 | $60.58 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexARKG | PTH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 6:40 PM
Live
Closed
ARKG | PTH | |
|---|---|---|
| Last price | $45.75 | $61.84 |
| 1D performance | +0.80% | +2.08% |
| AuM | $1.84 B | $282.92 M |
| E/R | 0.75% | 0.72% |
Characteristics
ARKG | PTH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Ark Investment | Invesco |
| Benchmark | - | Dorsey Wright Healthcare Technical Leaders Index |
| N° of holdings | 31 | 54 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | October 12, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
ARKG
USA
88.43%
Other
11.57%
PTH
USA
89.98%
Other
10.02%
Sectors
ARKG
Healthcare
97.99%
Other
2.01%
PTH
Healthcare
99.16%
Other
0.84%
Advertisement
Diversification
ARKG
Total weight of top 15 holdings out of 15
75.55%
PTH
Total weight of top 15 holdings out of 15
47.09%
Top 15 holdings
Data as of July 31, 2026
ARKG
10X Genomics, Inc.
9.41%
Twist Bioscience Corp.
7.74%
Tempus AI, Inc.
6.57%
CRISPR Therapeutics AG
6.30%
Personalis, Inc.
5.48%
Absci Corp.
5.15%
Guardant Health, Inc.
4.75%
Illumina, Inc.
4.75%
Eli Lilly & Co.
4.69%
CareDx, Inc.
4.31%
Natera, Inc.
4.14%
Beam Therapeutics, Inc.
3.78%
Compass Pathways Plc
3.26%
Recursion Pharmaceuticals, Inc.
2.63%
Adaptive Biotechnologies Corp.
2.58%
PTH
Roivant Sciences Ltd.
4.88%
Revolution Medicines, Inc.
4.85%
BrightSpring Health Services, Inc.
4.77%
Guardant Health, Inc.
4.50%
Axsome Therapeutics, Inc.
4.38%
Liquidia Corp.
3.17%
Erasca, Inc.
2.92%
Oruka Therapeutics, Inc.
2.54%
10X Genomics, Inc.
2.27%
Relay Therapeutics, Inc.
2.23%
Travere Therapeutics, Inc.
2.18%
Agilon Health, Inc.
2.13%
Oscar Health, Inc.
2.09%
Arrowhead Pharmaceuticals, Inc.
2.09%
Tango Therapeutics, Inc.
2.09%
Frequently asked questions about ARKG and PTH
How have the ARKG and PTH ETFs performed in 2026?
As of September 10, 2026, ARKG is up 55.33% year-to-date (YTD), while PTH has returned 21.86%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or PTH?
Year-to-date, the ARKG ETF saw +$52M in flows, compared to +$131M for PTH.
Which ETF is more volatile: ARKG or PTH?
Over the past year, ARKG had a volatility of 44.21%, while PTH experienced 26.06%.
Which ETF is bigger: ARKG or PTH?
As of September 10, 2026, ARKG holds $1.84 B in assets under management (AUM), while PTH manages $282.92 M.
What sectors do the ARKG and PTH ETFs invest in?
ARKG leans toward sectors like Healthcare. Meanwhile, PTH focuses on Healthcare.
What are the top holdings of the ARKG ETF and PTH ETF?
ARKG top holdings include 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc.. PTH holds in its top three: Roivant Sciences Ltd., Revolution Medicines, Inc. and BrightSpring Health Services, Inc..
Which ETF is more diversified: ARKG or PTH?
ARKG holds 31 securities with 75.55% of its assets in the top 15. PTH has 54 securities and a top 15 weight of 47.09%.
Advertisement
Latest news about ARKG & PTH
Continued tightening of the U.S. labor market
September 23, 2022
PTH
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
